Talk:Assessment of the health impacts of H1N1 vaccination/Group B
Pandemrix should not be used because of narcolepsy risk
| Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
| Argumentation:
⇤# : All data compiled to date indicate that pandemic vaccines including Pandemrix match the excellent safety profile of seasonal influenza vaccines, which have been used for more than 60 years. --Oluyemitoyinbo 11:12, 1 April 2011 (EEST) ⇤# : Adjuvanted vaccines commonly provide a stronger immune response than unadjuvanted vaccines and also provide a broader immune response allowing for some potential drift of the influenza virus (Pandemrix is an adjuvanted vaccine). --Oluyemitoyinbo 11:12, 1 April 2011 (EEST) ⇤# : The number of cases of side effects of H1N1 vaccines (including Pandemrix) is in line with normal background rates on a population basis, as reported in a recent study European Medicines Agency --Oluyemitoyinbo 11:12, 1 April 2011 (EEST) ⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) ⇤# : No link to the vaccine has been established concerning the side effect. --Oluyemitoyinbo 11:20, 1 April 2011 (EEST) ⇤# : A positive effect of the vaccine can be felt from pregnant women --Oluyemitoyinbo 11:20, 1 April 2011 (EEST) ←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)
|
